FCSR Logo

  • Home
  • Financial Conflict of Interest in Research
  • Research
  • Homepage

DIAMOnD – Development of an Inhaled Antibiotic with a novel MOde of action active against multi-Drug resistant Pseudomonas aeruginosa

Published January 24, 2013 at 295 × 198 in DIAMOnD – Development of an Inhaled Antibiotic with a novel MOde of action active against multi-Drug resistant Pseudomonas aeruginosa.
← Previous Next →
Mappa del sito | Area Stampa | Benefici fiscali | Webmaster | FCSR Cookie Policy | Privacy Policy

Copyright Reserved ©. 2025